PIP
CELG

Palisades Investment Partners’s Celgene Corp CELG Stock Holding History

Palisades Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,800
Closed -$405K – 87
2014
Q1 		$405K Hold
5,800
– – 0.44% 78
2013
Q4 		$486K Sell
5,800
-2,000
-26% -$158K 0.54% 65
2013
Q3 		$601K Hold
7,800
– – 0.57% 60
2013
Q2 		$456K Buy
+7,800
New +$469K 0.45% 71

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Palisades Investment Partners's CELG Position: Q2 2014 in Review

Palisades Investment Partners sold out of Celgene Corp (CELG) in Q2 2014, closing a stake of 5,800 shares — an estimated $405K sold.

Palisades Investment Partners first reported a position in CELG in Q2 2013 and held it in 4 quarters. The position peaked at $601K in Q3 2013. 995 funds tracked by Wall St. Rank hold CELG as of Q2 2014.

  • Palisades Investment Partners reported no remaining Celgene Corp position as of Q2 2014 after selling out during the quarter.
  • Palisades Investment Partners sold 5,800 Celgene Corp shares in Q2 2014, an estimated $405K.
  • Palisades Investment Partners first reported a position in Celgene Corp in Q2 2013 and held it in 4 quarters.
  • Palisades Investment Partners's Celgene Corp position peaked at $601K in Q3 2013.
  • 995 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2014.

Based on Palisades Investment Partners's 13F filing for Q2 2014, filed 28 Jul 2014.